These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

540 related articles for article (PubMed ID: 25221796)

  • 1. Treatment of severe or progressive Kaposi's sarcoma in HIV-infected adults.
    Gbabe OF; Okwundu CI; Dedicoat M; Freeman EE
    Cochrane Database Syst Rev; 2014 Aug; 8(8):CD003256. PubMed ID: 25221796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of severe or progressive Kaposi's sarcoma in HIV-infected adults.
    Gbabe OF; Okwundu CI; Dedicoat M; Freeman EE
    Cochrane Database Syst Rev; 2014; (9):CD003256. PubMed ID: 25313415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of Kaposi's sarcoma in HIV-1 infected individuals with emphasis on resource poor settings.
    Dedicoat M; Vaithilingum M; Newton R
    Cochrane Database Syst Rev; 2003; (3):CD003256. PubMed ID: 12917957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A risk and benefit assessment of treatment for AIDS-related Kaposi's sarcoma.
    Nasti G; Errante D; Santarossa S; Vaccher E; Tirelli U
    Drug Saf; 1999 May; 20(5):403-25. PubMed ID: 10348092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapy of special HIV-associated diseases: HCV-HIV-co-infection and AIDS-related Kaposi's sarcoma - official satellite to the 7th European Conference on Clinical Aspects and Treatment of HIV-infection, October 23, 1999 in Lisbon, Portugal.
    Goebel FD; Jablonowski H
    Eur J Med Res; 1999 Dec; 4(12):507-13. PubMed ID: 10611054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pegylated liposomal doxorubicin plus highly active antiretroviral therapy versus highly active antiretroviral therapy alone in HIV patients with Kaposi's sarcoma.
    Martin-Carbonero L; Barrios A; Saballs P; Sirera G; Santos J; Palacios R; Valencia ME; Alegre M; Podzamczer D; González-Lahoz J;
    AIDS; 2004 Aug; 18(12):1737-40. PubMed ID: 15280789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pegylated-liposomal doxorubicin versus doxorubicin, bleomycin, and vincristine in the treatment of AIDS-related Kaposi's sarcoma: results of a randomized phase III clinical trial.
    Northfelt DW; Dezube BJ; Thommes JA; Miller BJ; Fischl MA; Friedman-Kien A; Kaplan LD; Du Mond C; Mamelok RD; Henry DH
    J Clin Oncol; 1998 Jul; 16(7):2445-51. PubMed ID: 9667262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized phase III trial of liposomal daunorubicin versus doxorubicin, bleomycin, and vincristine in AIDS-related Kaposi's sarcoma.
    Gill PS; Wernz J; Scadden DT; Cohen P; Mukwaya GM; von Roenn JH; Jacobs M; Kempin S; Silverberg I; Gonzales G; Rarick MU; Myers AM; Shepherd F; Sawka C; Pike MC; Ross ME
    J Clin Oncol; 1996 Aug; 14(8):2353-64. PubMed ID: 8708728
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized comparative trial of pegylated liposomal doxorubicin versus bleomycin and vincristine in the treatment of AIDS-related Kaposi's sarcoma. International Pegylated Liposomal Doxorubicin Study Group.
    Stewart S; Jablonowski H; Goebel FD; Arasteh K; Spittle M; Rios A; Aboulafia D; Galleshaw J; Dezube BJ
    J Clin Oncol; 1998 Feb; 16(2):683-91. PubMed ID: 9469358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polyethylene glycol-liposomal doxorubicin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the management of AIDS-related Kaposi's sarcoma.
    Coukell AJ; Spencer CM
    Drugs; 1997 Mar; 53(3):520-38. PubMed ID: 9074848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemotherapy for AIDS-related and endemic African Kaposi's sarcoma in southern Africa.
    Stein ME; Lachter J; Spencer D; Bezwoda WR
    Int J Dermatol; 1995 Oct; 34(10):729-32. PubMed ID: 8537166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of HIV-1-associated Kaposi's sarcoma with pegylated liposomal doxorubicin and HAART simultaneously induces effective tumor remission and CD4+ T cell recovery.
    Lichterfeld M; Qurishi N; Hoffmann C; Hochdorfer B; Brockmeyer NH; Arasteh K; Mauss S; Rockstroh JK;
    Infection; 2005 Jun; 33(3):140-7. PubMed ID: 15940415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemic treatment of AIDS-related Kaposi's sarcoma: results of a randomized trial.
    Gill PS; Rarick M; McCutchan JA; Slater L; Parker B; Muchmore E; Bernstein-Singer M; Akil B; Espina BM; Krailo M
    Am J Med; 1991 Apr; 90(4):427-33. PubMed ID: 1707230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kaposi's sarcoma in children: an open randomised trial of vincristine, oral etoposide and a combination of vincristine and bleomycin.
    Chagaluka G; Stanley C; Banda K; Depani S; Nijram'madzi J; Katangwe T; Israels T; Bailey S; Mukaka M; Molyneux E
    Eur J Cancer; 2014 May; 50(8):1472-81. PubMed ID: 24636877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polyethylene glycol-liposomal doxorubicin: a review of its use in the management of solid and haematological malignancies and AIDS-related Kaposi's sarcoma.
    Sharpe M; Easthope SE; Keating GM; Lamb HM
    Drugs; 2002; 62(14):2089-126. PubMed ID: 12269857
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kaposi's sarcoma in HIV-infected patients in the era of new antiretrovirals.
    Facciolà A; Venanzi Rullo E; Ceccarelli M; D'Aleo F; Di Rosa M; Pinzone MR; Condorelli F; Visalli G; Picerno I; Fisichella R; Nunnari G; Pellicanò GF
    Eur Rev Med Pharmacol Sci; 2017 Dec; 21(24):5868-5869. PubMed ID: 29272026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of liposomal anthracyclines in Kaposi's sarcoma.
    Krown SE; Northfelt DW; Osoba D; Stewart JS
    Semin Oncol; 2004 Dec; 31(6 Suppl 13):36-52. PubMed ID: 15717737
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Kaposi's sarcoma].
    Imamura A
    Gan To Kagaku Ryoho; 2003 May; 30(5):634-9. PubMed ID: 12795094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kaposi's sarcoma: Good outcome with doxorubicin, bleomycin and vincristine sulphate (ABV) chemotherapy and highly active antiretroviral therapy.
    Hesseling PB; Katayi E; Wharin P; Bardin R; Kouya F; Palmer D; Glenn M; Kruger M
    S Afr Med J; 2017 Oct; 107(11):952-953. PubMed ID: 29262935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of advanced AIDS-associated Kaposi sarcoma in resource-limited settings: a three-arm, open-label, randomised, non-inferiority trial.
    Krown SE; Moser CB; MacPhail P; Matining RM; Godfrey C; Caruso SR; Hosseinipour MC; Samaneka W; Nyirenda M; Busakhala NW; Okuku FM; Kosgei J; Hoagland B; Mwelase N; Oliver VO; Burger H; Mngqibisa R; Nokta M; Campbell TB; Borok MZ;
    Lancet; 2020 Apr; 395(10231):1195-1207. PubMed ID: 32145827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.